Verisk Analytics, Inc.

Verisk Analytics — Business Economics

Ticker: VRSK | Currency: USD

Verisk is a toll-booth business embedded in the plumbing of the U.S. property & casualty insurance industry. Its economic engine is strengthening, not weakening.

How it makes money. Verisk collects granular data from ~99% of the U.S. P&C market (premiums, claims, actuarial data) through its ISO statistical agent role — a quasi-regulatory function mandated by state insurance departments. It then sells analytics, rating algorithms, catastrophe models (AIR), fraud-detection tools, and policy-language products back to the same insurers on long-term subscriptions. Revenue is ~80% subscription/recurring, with multi-year contracts and annual price escalators. After divesting Wood Mackenzie (2023) and Financial Services, Verisk is now a pure-play insurance analytics company generating ~$2.9B in FY2025 revenue with EBITDA margins in the mid-50s%.

Why the engine is strengthening. Organic revenue growth has accelerated from ~5% pre-COVID to the 7–9% range post-divestiture, driven by (1) hardening P&C insurance markets boosting premium volumes (Verisk's revenue is partially tied to insured values/premiums), (2) increasing climate-risk complexity making catastrophe models indispensable, and (3) cross-selling new SaaS products into the installed base. The transition from on-premise to cloud-hosted delivery creates a tailwind for years as it enables premium pricing and better retention.

Win-win model. This is a genuine mutualistic ecosystem. Insurers pool anonymized data into Verisk's cooperative database; Verisk enriches it and returns analytics that no individual insurer could build alone. Regulators benefit from standardized data. There is no extractive dynamic — customers save multiples of what they pay.

Signs of deterioration: None. Net retention rates are high (mid-to-high 90s%), there are no meaningful competitors for the core ISO/actuarial data, and no segment is shrinking. The only structural risk is regulatory — if state insurance regulators changed the statistical-agent framework, the moat would weaken, but there is no indication of this.

Key metrics: Organic constant-currency revenue growth, subscription revenue as % of total, EBITDA margin, and free-cash-flow conversion (consistently >100% of net income).

Market Overview — Verisk Analytics

Verisk operates in the U.S. P&C insurance data and analytics market — a structural tailwind business tied to insurance premium growth, climate complexity, and digital adoption.

The addressable market for insurance data, analytics, and workflow software is estimated at ~$15–20B globally, growing mid-to-high single digits annually as insurers invest in catastrophe modeling, AI-driven underwriting, and regulatory compliance. U.S. P&C net premiums written have compounded at ~7–9% in recent years, driven by rate hardening and climate-related losses, directly expanding Verisk's subscription base.

The competitive landscape around Verisk's core is effectively a monopoly. ISO's contributory database — built over a century of insurer data sharing — has no substitute; it is the statutory rating backbone for U.S. P&C. Adjacent competitors (Guidewire in core systems, CoreLogic in property data) occupy different value-chain layers and are more complementary than threatening. The market is highly consolidated at the data layer and fragmented only at the application layer, where Verisk increasingly competes.

Verisk's moat is among the deepest in all of software — it is the irreplaceable data infrastructure of U.S. P&C insurance, not merely a vendor to it.

Data monopoly with regulatory entrenchment. Verisk's ISO subsidiary has collected loss-cost, actuarial, and claims data from ~99% of U.S. P&C insurers for over 50 years. This dataset is self-reinforcing: insurers must contribute data to access the pool, which makes the pool more comprehensive, which makes participation non-optional. State regulators designate Verisk as a licensed statistical agent — a quasi-governmental role with no meaningful competing applicant. ISO policy forms and classification codes are the literal language of U.S. insurance contracts, cited in court rulings and taught in actuarial curricula.

Switching costs are existential, not merely inconvenient. Verisk's analytics sit inside underwriting engines, claims workflows, and regulatory filings. Ripping them out would mean re-filing rates with every state regulator, retraining actuarial staff, and rebuilding models — all to save a subscription that costs basis points of premiums written. No rational insurer would do this.

Trajectory: widening. The SaaS migration (Lightspeed platform) deepens integration, and new products (climate/catastrophe modeling, ESG analytics, IoT/telematics data) extend the data flywheel into adjacent decision layers where Verisk faces even less competition.

Verisk is a financial fortress, though its balance sheet optics require looking past negative book equity to see the underlying economics clearly.

Returns on capital are elite. Conventional ROE is undefined — stockholders' equity has been negative since ~2021, driven by $10B+ in cumulative share repurchases. This isn't distress; it's a capital-light business returning nearly all earnings to shareholders. ROIC on gross invested capital runs ~25–30%, consistently 3–4× a reasonable cost of capital. Pre-tax margins near 45% and EBITDA margins in the mid-50s% confirm the economics are real.

Debt is purposeful, not reckless. Total debt of ~$3.0B against ~$1.7B EBITDA yields net leverage of ~1.7×. Interest coverage exceeds 8×. Maturities are well-laddered, investment-grade rated (Baa2/BBB). This is comfortably serviceable even in a deep soft market — P&C insurance data demand is non-cyclical, as underwriters need ISO data and claims analytics regardless of premium volume.

Earnings quality is exceptional. FCF consistently exceeds net income (conversion ratio ~110–120%) because D&A from prior acquisitions exceeds maintenance capex by a wide margin. Capex runs only ~6% of revenue. No unusual receivables growth or revenue recognition concerns. Goodwill (~$2B post-divestitures) is concentrated in durable, monopoly-like data assets with no impairment indicators.

No hidden landmines. No material off-balance-sheet liabilities. No customer concentration — Verisk serves virtually every U.S. P&C insurer. No related-party concerns. The negative equity is purely a function of buyback math, not operational deterioration.

Runway for Reinvestment

Verisk is a capital-light compounder that returns most of its FCF rather than reinvesting it — and that's the right move. With capex needs of only ~$230–250M (including capitalized software) against ~$1.0–1.1B in FCF, the business generates far more cash than it can organically redeploy. Returns on incremental invested capital are exceptional — likely 40%+ — but the quantum of reinvestable capital is inherently limited by the niche it dominates.

Post-divestiture, management has been disciplined: minimal M&A, aggressive buybacks funded partly by leverage, and a growing dividend. Buybacks at 25–30× earnings for a business with mid-to-high-single-digit organic growth and expanding margins are defensible but not obviously accretive. The runway is long but narrow — Verisk can sustain high returns for a decade, but it cannot dramatically scale reinvestment.

Verisk has no direct peer — its ISO statistical-agent franchise is a regulated monopoly with no substitute. The relevant comparison is business-model twins: other embedded data monopolies with high recurring revenue and pricing power across different verticals.

Within insurance, LexisNexis Risk Solutions (RELX) competes in claims analytics and fraud, CCC Intelligent Solutions in auto claims, and Guidewire in core systems — but none contest Verisk's rating/actuarial data franchise. These are adjacent, not head-to-head competitors. Verisk is gaining share through cross-sell (Life, Specialty, international) and platform migration (LightSpeed, Predict), not by taking customers from rivals.

Verisk's organic growth trails SPGI/MSCI/MCO, which benefit from capital-markets cyclicality. Its margin is peer-leading. The valuation premium over SPGI/MCO reflects single-vertical purity and defensibility, though MSCI commands more due to faster secular growth in indexing/ESG. The main risk isn't competition — it's that Verisk's TAM ceiling in U.S. P&C is narrower than peers operating across global capital markets.

Management & Shareholder Orientation

Verisk's management is well-aligned with long-term shareholders, anchored by disciplined capital allocation and a sensible compensation framework — though insider ownership is modest for a company of this quality.

Capital allocation is the strongest alignment signal. After divesting Wood Mackenzie for ~$3.1B in early 2023, management returned virtually all proceeds to shareholders via buybacks rather than empire-building. The share count declined from ~160M pre-divestiture to ~138M by early 2026 — roughly 14% reduction in three years. This was not a one-off: Verisk has been a consistent repurchaser for over a decade, funded by strong FCF conversion (60%+ FCF margins).

CEO Lee Shavel (appointed mid-2022, formerly CFO/COO) brings institutional continuity and a finance-first orientation. Executive compensation is predominantly performance-based, tied to organic revenue growth and adjusted EBITDA — the right metrics for a subscription data business. Stock ownership guidelines require executives to hold multiples of base salary.

Insider ownership is low in absolute terms — typical for a $40B+ company with no founder or controlling shareholder. There is no dual-class structure, no poison pill, and no concerning related-party transactions. The board is majority independent. Insider transactions have been primarily routine selling through 10b5-1 plans at elevated prices, not a red flag given stock appreciation but not a confidence signal either.

Institutional register skews toward quality-oriented, long-duration holders (Vanguard, BlackRock, T. Rowe Price among top holders), consistent with the business profile. No known regulatory actions against the company or its leadership.

Verisk's management has been sharply value-creative since CEO Lee Shavel took over in 2022. The defining capital allocation decision — divesting Wood Mackenzie (~$3.1B), Financial Services, and Specialty Markets to become a pure-play insurance analytics company — corrected what were arguably value-dilutive diversifications under predecessor Scott Stephens (Wood Mackenzie was acquired for ~$2.8B in 2015 and sold at roughly cost after years of below-core-business returns). Divestiture proceeds funded >$5B in buybacks, shrinking shares from ~163M (2021) to ~138M (early 2026) — a meaningful per-share value accelerator on a business with 80%+ subscription revenue and mid-50s% EBITDA margins.

Execution is strong. Management laid out a post-divestiture framework targeting 7%+ organic growth and margin expansion; actual results have consistently met or slightly exceeded those targets, with organic growth running 7–8% and margins expanding. Guidance has been reliable, not aspirational.

No red flags on integrity. There are no financial restatements, no auditor disagreements, no whistleblower complaints, and no fraud allegations in Verisk's history. Legal proceedings disclosed in the 10-K are routine and immaterial. The company proactively discusses headwinds (e.g., transactional revenue lumpiness, international ramp timelines) without obscuring them.

The one criticism: the pre-Shavel era of serial diversifying acquisitions (Wood Mac, Financial Services) burned capital for a decade before being unwound. The current regime has earned credibility but the institutional memory matters — governance permitted that dilution for years.

Verisk Analytics — Valuation

Verisk is fairly valued with a tilt toward cheap at the current $24.9B market cap. The stock sits 30% below its 52-week high of $274, yet the underlying business just delivered its strongest FCF year ever ($1.19B). The compression from ~35x historical P/E toward ~29x trailing (22x forward) creates a reasonable entry point for a monopolistic, subscription-driven franchise.

What's embedded in the current price? At $191, the market prices roughly 7% revenue growth, modest margin expansion, and continued buybacks — essentially management's own playbook. Assuming a 9% required return less ~1% dividend yield, the stock needs ~8% annual capital appreciation. That demands ~$1.5B net income by 2031 at a 24x terminal P/E — achievable with 7% revenue CAGR, 200bps of cumulative margin expansion, and 3% annual share count reduction. The embedded assumptions are undemanding for this quality tier.

Liquidation value is irrelevant. Tangible book is negative $1.9B — this is a franchise business where the moat lives in proprietary data networks and regulatory entrenchment, not hard assets.

Management guidance and credibility. Verisk has consistently guided for mid-to-high single-digit organic revenue growth with 50-100bps of annual EBITDA margin expansion. Post-divestiture track record (2023-2025) shows 7.1% revenue CAGR and operating income growing from $1.13B to $1.34B. Guidance credibility is high.

Probability-weighted expected market cap: ~$32B — implying ~29% total upside plus dividends, or roughly 9-10% annualized total return. For a 0.66-beta, quasi-monopoly business, that's an attractive risk-adjusted proposition, though not a screaming bargain.

Verisk's compounding engine is straightforward: 7–8% organic revenue growth plus 3–4% annual share-count reduction from buybacks yields 10–12% EPS growth with minimal capital intensity. FCF conversion is exceptional — $1.19B on $3.07B revenue (39% FCF margin) — because the business requires negligible incremental capital to grow; the datasets, models, and regulatory moats were built decades ago.

Moat longevity is the key variable. ISO's position as the de facto statistical agent for U.S. P&C insurance is quasi-regulatory — insurers are often required to use ISO forms and loss costs. This is not a moat that erodes gradually; it holds until a structural event (regulatory revocation, antitrust action, or a consortium of top-10 carriers building an alternative). None of these appears imminent. Reinvesting profits does widen the moat: each new analytics module (Lightspeed, ClaimSearch, Sequel for specialty) raises switching costs further.

10-year return math at $191: EPS of ~$6.50 growing at 11% reaches ~$18.50. Apply a 25x terminal multiple (modest compression from today's 29x) → ~$460, or ~2.4x. Dividend adds another ~$25 cumulative. Downside floor: even at 20x terminal, the stock reaches ~$370 (1.9x). The risk is overpaying at a premium multiple for mid-single-digit topline growth.

Thesis-breaking signal: Organic revenue growth sustained below 4% for two or more years — that would indicate pricing power erosion or carrier disintermediation, the only plausible moat failure modes.

Risk Assessment — Verisk Analytics (VRSK)

Verisk's risk of permanent impairment is among the lowest in the market. The business sits inside a regulatory-granted franchise — ISO operates as the dominant licensed statistical agent for U.S. P&C insurance, a role that has been structurally stable for over 50 years. Insurers are legally required to report loss data to statistical agents; ISO aggregates and returns it as actuarial products. This is infrastructure, not a vendor relationship.

Business risk is negligible. No credible competitor can replicate ISO's contributory data network — it is a self-reinforcing loop where every insurer's participation makes the dataset more valuable for all. AI/insurtech disruption affects the analytics layer, not the data layer, and Verisk is itself the largest buyer of AI talent in insurance analytics. Customer concentration is a non-issue: all top-100 U.S. P&C insurers are clients, none >10% of revenue.

Financial risk is minimal. ~$3B net debt against ~$1.6B EBITDA (FY2025) yields ~1.9x leverage — comfortable for a subscription business converting >50% of EBITDA to free cash flow. Interest coverage is ample. No refinancing cliff.

The single risk that could permanently impair this business is regulatory or antitrust action dismantling the statistical agent framework — forcing open access to contributory data or eliminating the mandated reporting structure. Probability over a 10-year horizon: <5%. The framework serves all stakeholders — insurers need pooled data for pricing accuracy, regulators need it for rate review, consumers benefit from actuarially sound pricing. No constituency is lobbying to dismantle it.

Cybersecurity is the most realistic operational risk — Verisk holds billions of sensitive records. A major breach could cause reputational damage, though the embedded nature of ISO data in regulatory workflows limits customer switching even in a breach scenario.

Final Verdict: Verisk Analytics (VRSK)

BUY — a rare monopoly franchise available at a reasonable price near its 52-week low.

Verisk is one of the highest-quality businesses in public markets. A regulatory-granted statistical agent monopoly with a 50-year irreplicable dataset, mid-50s% EBITDA margins, 39% FCF margins, and near-zero churn is not something you encounter often. The moat is not just wide — it is structurally un-attackable. No startup can replicate mandated industry data submissions, and no insurer can operate without Verisk's ISO forms and actuarial data. This is as close to a permanent franchise as exists.

The strongest argument against owning Verisk is that it is a slow compounder. Mid-single-digit organic revenue growth (~7%), limited reinvestment capacity at monopoly returns, and a TAM ceiling in U.S. P&C insurance mean this will never be a 15%+ annualized compounder. At $191 and a $24.86B market cap, the base case yields ~$33B by 2031 — roughly 9-10% annualized total returns including buybacks and dividends. That is adequate, not exceptional.

But adequate returns on a business with near-zero probability of permanent capital loss is a compelling risk-adjusted proposition. The risk score across every segment was the lowest I have seen: no leverage concern (2.9x net debt/EBITDA), no governance flags, no credible disruption vector. The stock sits 30% below its 52-week high, offering the best entry point in over a year.

For new investors: Build a moderate position at current levels. This is not a fat pitch requiring maximum allocation — the growth ceiling prevents that — but it is a high-quality compounder at a fair price. Add on further weakness toward $170.

For existing holders: Hold. The thesis is intact and the valuation has improved. No reason to trim.

What could change this to STRONG_BUY: A pullback to ~$160-170 (18-19x forward earnings), or evidence that AI/climate analytics meaningfully accelerate organic growth above 9%.

Gaps to monitor: International expansion traction, AI product monetization trajectory, and whether the $4.9B total debt (up from $3.25B in 2024) reflects an acquisition or capital structure decision.